Matches in SemOpenAlex for { <https://semopenalex.org/work/W2047101312> ?p ?o ?g. }
- W2047101312 endingPage "377" @default.
- W2047101312 startingPage "367" @default.
- W2047101312 abstract "Abstract Anaplastic thyroid cancer (ATC) is one of the most lethal human malignancies, but its genetic drivers remain little understood. In this study, we report losses in expression of the miRNA miR30a, which is downregulated in ATC compared with differentiated thyroid cancer and normal tissue. miR30a downregulation was associated with advanced differentiated thyroid cancer and higher mortality. Mechanistically, we found miR30a decreased cellular invasion and migration, epithelial–mesenchymal transition marker levels, lysyl oxidase (LOX) expression, and metastatic capacity. LOX was identified as a direct target of miR30a that was overexpressed in ATC and associated with advanced differentiated thyroid cancer and higher mortality rate. Consistent with its role in other cancers, we found that LOX inhibited cell proliferation, cellular invasion, and migration and metastasis in vitro and in vivo. Together, our findings establish a critical functional role for miR30a downregulation in mediating LOX upregulation and thyroid cancer progression, with implications for LOX targeting as a rational therapeutic strategy in ATC. Cancer Res; 75(2); 367–77. ©2014 AACR." @default.
- W2047101312 created "2016-06-24" @default.
- W2047101312 creator A5005450827 @default.
- W2047101312 creator A5006574108 @default.
- W2047101312 creator A5009614635 @default.
- W2047101312 creator A5013942288 @default.
- W2047101312 creator A5040666076 @default.
- W2047101312 creator A5046576171 @default.
- W2047101312 creator A5050780818 @default.
- W2047101312 creator A5051670486 @default.
- W2047101312 creator A5052550088 @default.
- W2047101312 creator A5060590657 @default.
- W2047101312 creator A5074325574 @default.
- W2047101312 creator A5076916905 @default.
- W2047101312 creator A5091514582 @default.
- W2047101312 date "2015-01-14" @default.
- W2047101312 modified "2023-10-11" @default.
- W2047101312 title "miR30a Inhibits LOX Expression and Anaplastic Thyroid Cancer Progression" @default.
- W2047101312 cites W1516816071 @default.
- W2047101312 cites W1966347977 @default.
- W2047101312 cites W1967682615 @default.
- W2047101312 cites W1986861417 @default.
- W2047101312 cites W1990785257 @default.
- W2047101312 cites W1994061059 @default.
- W2047101312 cites W1998915601 @default.
- W2047101312 cites W1998990473 @default.
- W2047101312 cites W2003285711 @default.
- W2047101312 cites W2025918688 @default.
- W2047101312 cites W2027795228 @default.
- W2047101312 cites W2033363278 @default.
- W2047101312 cites W2033980810 @default.
- W2047101312 cites W2045755466 @default.
- W2047101312 cites W2055801606 @default.
- W2047101312 cites W2059382687 @default.
- W2047101312 cites W2065418531 @default.
- W2047101312 cites W2074867550 @default.
- W2047101312 cites W2081119041 @default.
- W2047101312 cites W2085225921 @default.
- W2047101312 cites W2088651729 @default.
- W2047101312 cites W2093589216 @default.
- W2047101312 cites W2105743205 @default.
- W2047101312 cites W2108668400 @default.
- W2047101312 cites W2113134419 @default.
- W2047101312 cites W2117444024 @default.
- W2047101312 cites W2118258530 @default.
- W2047101312 cites W2122413456 @default.
- W2047101312 cites W2138954682 @default.
- W2047101312 cites W2145400675 @default.
- W2047101312 cites W2158485828 @default.
- W2047101312 cites W2161149887 @default.
- W2047101312 doi "https://doi.org/10.1158/0008-5472.can-14-2304" @default.
- W2047101312 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6986377" @default.
- W2047101312 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25488748" @default.
- W2047101312 hasPublicationYear "2015" @default.
- W2047101312 type Work @default.
- W2047101312 sameAs 2047101312 @default.
- W2047101312 citedByCount "62" @default.
- W2047101312 countsByYear W20471013122015 @default.
- W2047101312 countsByYear W20471013122016 @default.
- W2047101312 countsByYear W20471013122017 @default.
- W2047101312 countsByYear W20471013122018 @default.
- W2047101312 countsByYear W20471013122019 @default.
- W2047101312 countsByYear W20471013122020 @default.
- W2047101312 countsByYear W20471013122021 @default.
- W2047101312 countsByYear W20471013122022 @default.
- W2047101312 countsByYear W20471013122023 @default.
- W2047101312 crossrefType "journal-article" @default.
- W2047101312 hasAuthorship W2047101312A5005450827 @default.
- W2047101312 hasAuthorship W2047101312A5006574108 @default.
- W2047101312 hasAuthorship W2047101312A5009614635 @default.
- W2047101312 hasAuthorship W2047101312A5013942288 @default.
- W2047101312 hasAuthorship W2047101312A5040666076 @default.
- W2047101312 hasAuthorship W2047101312A5046576171 @default.
- W2047101312 hasAuthorship W2047101312A5050780818 @default.
- W2047101312 hasAuthorship W2047101312A5051670486 @default.
- W2047101312 hasAuthorship W2047101312A5052550088 @default.
- W2047101312 hasAuthorship W2047101312A5060590657 @default.
- W2047101312 hasAuthorship W2047101312A5074325574 @default.
- W2047101312 hasAuthorship W2047101312A5076916905 @default.
- W2047101312 hasAuthorship W2047101312A5091514582 @default.
- W2047101312 hasBestOaLocation W20471013121 @default.
- W2047101312 hasConcept C104317684 @default.
- W2047101312 hasConcept C121608353 @default.
- W2047101312 hasConcept C126322002 @default.
- W2047101312 hasConcept C127561419 @default.
- W2047101312 hasConcept C189165786 @default.
- W2047101312 hasConcept C193143273 @default.
- W2047101312 hasConcept C2779013556 @default.
- W2047101312 hasConcept C2779256057 @default.
- W2047101312 hasConcept C2779761222 @default.
- W2047101312 hasConcept C2780256643 @default.
- W2047101312 hasConcept C502942594 @default.
- W2047101312 hasConcept C526584372 @default.
- W2047101312 hasConcept C54355233 @default.
- W2047101312 hasConcept C55493867 @default.
- W2047101312 hasConcept C62112901 @default.
- W2047101312 hasConcept C71924100 @default.
- W2047101312 hasConcept C76419328 @default.